SCHILKE, EDOARDO DALMATO
SCHILKE, EDOARDO DALMATO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Analysis of an innovative fluid biomarker panel for early prediction of progression independent of relapse activity in multiple sclerosis
2025 Schilke, E; Frigo, M; Fusco, M; Cappellani, A; Cereda, D; Zoia, C; Cavaletti, G
Eculizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report
2025 Schilke, E; Cereda, D; Fusco, M; Stanzani, L; Marzorati, L; Ripolone, M; Bertolasi, L; Frigo, M; Molteni, F; Farina, N; Ferrarese, C; Cavaletti, G; Balducci, C
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis
2025 De Rosa, G; Russo, C; Garavelli, S; Di Silvestre, D; Spatocco, I; Mele, G; Rocca, C; Colamatteo, A; Carbone, F; Fusco, C; Passaro, F; Carpi, D; Tagliabue, E; Prattichizzo, F; Brambilla, F; Mauri, P; Hoxha, M; Bollati, V; Giusti, I; Dolo, V; D'Antona, P; Campomenosi, P; Mangolini, V; Radeghieri, A; Bergese, P; Morabito, I; Mandelli, A; Finardi, A; Beretta, F; Schilke, E; Cavaletti, G; Dolcetti, E; Buttari, F; Abbadessa, G; Bonavita, S; Lus, G; Signoriello, E; Lanzillo, R; Morra, V; Mottola, M; Zuccarelli, B; Uccelli, A; Salvetti, M; Centonze, D; Furlan, R; Matarese, G; Procaccini, C; De Candia, P
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX)
2025 Pupillo, E; Bianchi, E; Beghi, E; Pedrazzini, F; Giglio, A; Schilke, E; Percetti, M; Colleoni, C; Mainini, G; Calabresi, P; Primiano, G; Frisullo, G; Padovani, A; Cristillo, V; Pilotto, A; Arici, D; Gipponi, S; Tedeschi, G; D'Ambrosio, A; Melisi, R; Gallo, A; Bisecco, A; Salmaggi, A; Basilico, P; Scaccabarozzi, C; Kiferle, L; Valenti, R; Avino, G; Borghi, A; Contardi, S; Zini, A; Ferrarese, C; Beretta, S
Corticosteroid treatment for acute hydrocephalus in neurosarcoidosis: a case report
2024 Schilke, E; Remoli, G; Cutellé, C; Balducci, C; Cereda, D; Fusco, M; Tremolizzo, L; Ferrarese, C; Appollonio, I; Frigo, M
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials
2024 Schilke, E; Remoli, G; Funelli, E; Galimberti, M; Fusco, M; Cereda, D; Balducci, C; Frigo, M; Cavaletti, G
Neuropathological hints from CSF and serum biomarkers in corticobasal syndrome (CBS): a systematic review
2024 Remoli, G; Schilke, E; Magi, A; Ancidoni, A; Negro, G; Da Re, F; Frigo, M; Giordano, M; Vanacore, N; Canevelli, M; Ferrarese, C; Tremolizzo, L; Appollonio, I
Use of fluid biomarkers in ongoing Clinical Trials on Multiple Sclerosis (MS)
2023 Schilke, E; Remoli, G; Galimberti, M; Funelli, E; Fusco, M; Frigo, M; Ferrarese, C
Chorea and basal ganglia hypermetabolism as indicators of APS and probable-APS
2022 Schilke, E; Cutellé, C; Frigo, M; Da Re, F; Appollonio, I; Ferrarese, C
Tics: neurological disorders determined by a deficit in sensorimotor gating processes
2022 Schilke, E; Tremolizzo, L; Appollonio, I; Ferrarese, C